Oncology & CAR-T Therapy
Approved CAR-T cell therapies at roughly one-third of US pricing. Strong centres: Sun Yat-sen Cancer Center (Guangzhou), Fudan Shanghai Cancer Center, PUMC. Diagnosis-to-surgery in 1–2 weeks on average.
- 600+ active CAR-T trials — the world's largest cell-therapy pipeline
- Approved CAR-T at ≈ $135,000–180,000 vs $460,000–595,000 US list price
- First consult to surgery in 1–2 weeks at high-volume cancer centres